Form 10-K 23andMe Holding Co. For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500, Dow futures dip as big banks' earnings roll in ahead of CPI data; IBM slides
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- SK Hynix’s record plunge drags down global chip stocks
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- IBM misses Q2 targets as mainframe and software sales disappoint
- Goldman Sachs Upgrades NIO (NIO) to Buy
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
Citi Reiterates Neutral Rating on 23andMe Holding (ME)
June 3, 2024 3:17 PM EDTCiti analyst Daniel Grosslight reiterated a Neutral rating and $0.63 price target on 23andMe Holding (NASDAQ: ME).
The analyst comments "At the 2024 American Society of Clinical Oncology (ASCO) meeting, 23andMe presented early Ph2 data (as part of its ongoing Ph1/2a trial) for... More
